Literature DB >> 31302829

Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients.

Pierre Chelle1, Cindy H T Yeung2, Santiago Bonanad3, Juan Cristóbal Morales Muñoz4, Margareth C Ozelo5, Juan Eduardo Megías Vericat3, Alfonso Iorio2,6, Jeffrey Spears7, Roser Mir8, Andrea Edginton9.   

Abstract

The article Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients, written by Pierre Chelle, Cindy H. T. Yeung, Santiago Bonanad, Juan Cristóbal Morales Muñoz, Margareth C. Ozelo, Juan Eduardo Megías Vericat, Alfonso Iorio, Jeffrey Spears, Roser Mir, Andrea Edginton, was originally published electronically on the publisher's internet portal (currently SpringerLink) on 21 May 2019 without open access.

Entities:  

Year:  2019        PMID: 31302829      PMCID: PMC6820592          DOI: 10.1007/s10928-019-09647-2

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


Correction to: Journal of Pharmacokinetics and Pharmacodynamics 10.1007/s10928-019-09637-4

The article Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients, written by Pierre Chelle, Cindy H. T. Yeung, Santiago Bonanad, Juan Cristóbal Morales Muñoz, Margareth C. Ozelo, Juan Eduardo Megías Vericat, Alfonso Iorio, Jeffrey Spears, Roser Mir, Andrea Edginton, was originally published electronically on the publisher's internet portal (currently SpringerLink) on 21 May 2019 without open access. With the author(s)' decision to opt for Open Choice the copyright of the article changed on July 2019 to © The Author(s) 2019 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
  1 in total

1.  Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup.

Authors:  Pierre Chelle; Cindy H T Yeung; Stacy E Croteau; Jennifer Lissick; Vinod Balasa; Christina Ashburner; Young Shil Park; Santiago Bonanad; Juan Eduardo Megías-Vericat; Azusa Nagao; Tung Wynn; Fernando Corrales-Medina; Huyen Tran; Anjali Sharathkumar; Meera Chitlur; Samuel Sarmiento; Andrea Edginton; Alfonso Iorio
Journal:  Clin Pharmacokinet       Date:  2020-02       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.